Indian equity benchmarks rebounded on July 27, with the NSE Nifty 50 rising 229 points, or 0.96%, to close at 23,995.95, while the BSE Sensex gained 776 points, or 1.02%, ending at 76,835.78. This recovery followed a significant decline in global crude oil prices, attributed to easing geopolitical tensions between the U.S. and Iran, which contributed to improved investor sentiment.
Market Performance
The market breadth was favorable, with 2,259 stocks advancing compared to 1,072 declining across all listings. Sector performance was broad-based, with notable gains in Nifty Media (+2.39%), IT (+2.34%), Realty (+2.28%), Auto (+1.60%), and Pharma (+1.56%). The decline in oil prices, with Brent crude falling by 11% to around $88 per barrel, was a key factor in the market's positive movement, as noted by Siddhartha Khemka, Head of Research at Motilal Oswal Financial Services. He stated,
Indian equities are witnessing a short-term relief, as de-escalation in West Asia and the resultant fall in crude oil prices provided interim support.
Stock Recommendations
In light of the market rebound, Raja Venkatraman from NeoTrader recommended several stocks for trading on July 28. He suggested buying Saregama India Ltd at ₹518 with a target price of ₹575, and Dr. Lal PathLabs Ltd at ₹1,830 with a target price of ₹1,990. Both stocks are positioned to benefit from recent market trends and technical indicators, suggesting potential upward movement.
Related coverage: Indian Stocks Set for Positive Start Amid Easing Oil Prices.
The decline in oil prices is likely to benefit sectors sensitive to energy costs, particularly transportation and consumer goods, as lower crude prices can lead to reduced input costs. Investors will watch for further developments in U.S.-Iran relations and their impact on oil prices.
Watch for upcoming earnings reports from major companies, which could provide further insights into market trends and investor sentiment.